Less 'Experienced Weight Stigma' After Bariatric Surgery Aids Mental Health
FRIDAY, June 6, 2025 -- Experienced weight stigma (EWS) improves from pre- to post-metabolic bariatric surgery (MBS), according to a study published online June 5 in Health Psychology.
Larissa A. McGarrity, Ph.D., from the University of Utah in Salt Lake City, and colleagues used psychometrically validated measures to examine change in weight stigma from pre to post-MBS in a study involving 148 patients who completed both pre-MBS psychological examination and follow-up assessment 1.5 to 3.0 years post-MBS.
The researchers found that from pre- to post-MBS, EWS improved significantly, by both statistical and clinically meaningful standards. There was an association for this change with improvements in mental health, dysregulated eating, and reduced body mass index (BMI). Both changes in and post-MBS EWS predicted mental health, dysregulated eating, and BMI in regression models controlling demographic covariates and each outcome at baseline.
"Weight loss is helpful for a whole lot of things, but that change in weight stigma may actually be the more powerful thing for mental health and quality of life over time," McGarrity said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Once-Weekly Semaglutide 7.2 mg Beats Placebo for Obesity
THURSDAY, Sept. 18, 2025 -- In adults with obesity and those with type 2 diabetes and obesity, once-weekly semaglutide 7.2 mg is superior to placebo for body weight reduction...
Digital Intervention Aids Psychological Outcomes With Inflammatory Rheumatic Diseases
WEDNESDAY, Sept. 17, 2025 -- A digital psychological intervention is safe and effective for individuals with inflammatory rheumatic diseases (IRDs), according to a study published...
GLP-1 RAs Cost-Effective Versus Usual Care for Knee OA, Obesity
WEDNESDAY, Sept. 17, 2025 -- Compared with usual care, the glucagon-like peptide 1 receptor agonists (GLP-1 RAs) tirzepatide and semaglutide are cost-effective for people with...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.